Sun Pharma seals deal to acquire US-based InSite Vision
Drug major Sun Pharmaceutical Industries has entered into an agreement with InSite Vision to acquire the US-based eyecare firm for around USD 48 million plus related debt and other transaction costs to strengthen its branded ophthalmic portfolio in the US.
Sep 16, 2015, 11:21 AM IST